Featured News

Enveda: Cracking the chemical code of life with AI

At Enveda, we’re on a mission to deliver hope to every patient by transforming how the pharmaceutical industry discovers medicine. Our approach begins with a bold realization: over 99% of life’s chemistry may be unknown to science.

Read More

AI Drug Discovery Startup Enveda Raises $130 Million

2025 America’s Best Startup Employers

America’s Greatest Startup Workplaces 2025

Enveda raises $55M to combine ancient remedies with AI for drug discovery

Enveda translates life’s chemistry into medicines

TRANSFORMing natural product drug discovery: machine learning for high-fidelity chemical property prediction from metabolomics data

WHAT’S GOING ON AT ENVEDA

Press Releases

Enveda Reports Favorable Phase 1 Safety for Novel Oral Anti-Inflammatory, Launches Phase 1b Trial in Atopic Dermatitis

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

Enveda Welcomes Jason Kim as Chief Financial Officer

Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials

Enveda Biosciences unveils new AI algorithm to unlock nature’s chemical code

Enveda Biosciences Announces Microsoft Collaboration and Reveals Foundation Model to “Read and Translate” Chemistry

Enveda Biosciences Hires Chief Medical Officer to Advance Its Rich Pipeline of Therapeutic Programs into the Clinic

Copyright ©2025 ENVEDA All rights reserved

Site by Maven Creative